Herramientas para identificar deterioro cognitivo en pacientes adultos con síndrome post COVID 19 :Una revisión de alcance

Labrador Jiménez, Juan Sebastián

dc.contributor.advisor	García Gutiérrez, Liliana Margarita
dc.contributor.advisor	Jaimes Fernández, Diego Alejandro
dc.contributor.author	Labrador Jiménez, Juan Sebastián
dc.date.accessioned	2023-05-09T13:49:52Z
dc.date.available	2023-05-09T13:49:52Z
dc.date.issued	2023-02-11
dc.identifier.uri	http://hdl.handle.net/10818/55223
dc.description	22 páginas	es_CO
dc.description.abstract	La enfermedad por coronavirus del 2019 (COVID 19) supuso desde su inicio un reto para la humanidad. El daño a nivel de múltiples órganos y sistemas en su fase aguda genero altas tasas de mortalidad secundarias a compromisos severos del sistema respiratorio, circulatorio e inmune, cuyas consecuencias a largo plazo aún se mantienen en investigación. Dentro de las manifestaciones posteriores a la infección una de las más incapacitantes es el deterioro cognitivo secundario a la enfermedad, cuyo cribado y duración de la sintomatología se mantienen en estudio constante. Esta revisión de alcance busca dar al lector información sobre los instrumentos de detección de compromiso cognitivo disponibles usados hasta la fecha, junto con información sobre las áreas más afectadas y la duración de los síntomas Métodos: Siguiendo las 6 etapas de la metodología de Arksey y O´Malley se realizó una búsqueda iterativa de información en 8 bases de datos bibliográficas, la pregunta de investigación se asoció a los términos MeSH “Cognitive Dysfunction”, “Weights and Measures”, “COVID-19”, “Early Diagnosis” y “SARS-CoV-2”. Los estudios fueron seleccionados por 2 revisores y su contenido se analizó según las pautas PRISMA Resultados: Se obtuvieron 1457 documentos en la búsqueda final, tras la aplicación de los criterios de inclusión y exclusión se seleccionaron 24 artículos para su análisis, el 54 % (13) presentaron baterías de evaluación como estrategia más sensible para la detección de compromiso cognitivo post COVID19, la disfunción cognitiva reportada con mayor frecuencia fue en la función de la memoria en un 58% (14) de los artículos evaluados, seguida del compromiso de la función ejecutiva, la atención y la concentración. La duración de los síntomas cognitivos vario entre 1 y 72 semanas tras la infección.	es_CO
dc.format	application/pdf	es_CO
dc.language.iso	spa	es_CO
dc.publisher	Universidad de La Sabana	es_CO
dc.rights	Attribution-NonCommercial-NoDerivatives 4.0 Internacional	*
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/4.0/	*
dc.title	Herramientas para identificar deterioro cognitivo en pacientes adultos con síndrome post COVID 19 :Una revisión de alcance	es_CO
dc.type	bachelor thesis	es_CO
dc.identifier.local	291628
dc.identifier.local	TE12251
dc.type.hasVersion	publishedVersion	es_CO
dc.rights.accessRights	restrictedAccess	es_CO
dc.subject.armarc	COVID-19
dc.subject.armarc	Enfermos
dc.subject.armarc	Aparato respiratorio
dcterms.references	Kim SY, Kumble S, Patel B, Pruski AD, Azola A, Tatini AL et al. Managing the Rehabilitation Wave: Rehabilitation Services for COVID-19 Survivors. Arch Phys Med Rehabil 2020; 101: 2243.
dcterms.references	Kirtipal N, Bharadwaj S, Kang SG. From SARS to SARS-CoV-2, insights on structure, pathogenicity and immunity aspects of pandemic human coronaviruses. Infect Genet Evol 2020; 85: 104502.
dcterms.references	WHO Coronavirus (COVID-19) Dashboard \| WHO Coronavirus (COVID-19) Dashboard With Vaccination Data. https://covid19.who.int/ (accessed 21 Oct2021).
dcterms.references	Barker-Davies RM, O’Sullivan O, Senaratne KPP, Baker P, Cranley M, Dharm-Datta S et al. The Stanford Hall consensus statement for post-COVID-19 rehabilitation. Br J Sports Med 2020; : bjsports--2020--102596.
dcterms.references	Simpson R, Robinson L. Rehabilitation After Critical Illness in People With COVID-19 Infection. Am J Phys Med Rehabil 2020; 99: 470–474.
dcterms.references	S C, M I, G B, D B, F B, T D et al. COVID-19 pandemic. What should Physical and Rehabilitation Medicine specialists do? A clinician’s perspective. Eur J Phys Rehabil Med 2020; 56: 515–524.
dcterms.references	National Institute for Health and Care Excellence, Practitioners RC of G, Scotland HI. COVID-19 rapid guideline : managing the long-term effects of COVID-19. NICE Guidel 2020; : 1–35.
dcterms.references	Phillips S, Williams MA. Confronting Our Next National Health Disaster — Long-Haul Covid. N Engl J Med 2021; 385: 577–579.
dcterms.references	Walitt B, Johnson TP. The pathogenesis of neurologic symptoms of the postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection. Curr Opin Neurol 2022; 35: 384391.
dcterms.references	Domínguez-Chávez CJ, Murrock CJ, Salazar-González BC. Mild cognitive impairment: A concept analysis. Nurs Forum 2019; 54: 68–76.
dcterms.references	Souza ACC De, Braga-neto P. COVID-19 associated cognitive impairment : A systematic review. 2020.
dcterms.references	F. A, E. H, A. P, A. DF, A. S, S. A et al. COVID-19 cognitive deficits after respiratory assistance in the subacute phase: A COVID rehabilitation unit experience. PLoS One. 2021; 16.http://europepmc.org/search?query=(DOI:10.1371/journal.pone.0246590)%0Ahttps://doi .org/10.1371/journal.pone.0246590%0Ahttps://gateway.proquest.com/openurl?ctx_ver=Z39 .882004&res_id=xri:pqm&req_dat=xri:pqil:pq_clntid=47952&rft_val_fmt=ori/fmt:kev:mtx:jour.
dcterms.references	Miskowiak KW, Fugledalen L, Jespersen AE, Sattler SM, Podlekareva D, Rungby J et al. Trajectory of cognitive impairments over 1 year after COVID‐19 hospitalisation: Pattern, severity, and functional implications. Eur Neuropsychopharmacol 2022; 59: 82–92.
dcterms.references	Cecchetti G, Agosta F, Canu E, Basaia S, Barbieri A, Cardamone R et al. Cognitive, EEG, and MRI features of COVID-19 survivors: a 10-month study. J Neurol 2022; 269: 3400.
dcterms.references	Shi J, Gao Y, Zhao L, Li Y, Yan M, Niu MM et al. Prevalence of delirium, depression, anxiety, and post-traumatic stress disorder among COVID-19 patients: protocol for a living systematic review. Syst Rev 2020; 9. doi:10.1186/s13643-020-01507-2.
dcterms.references	Lou B, Guo J, Liu Y, Xiong C, Shi J, Zhou C. Prevalence, classification, risk factors and outcome impact of delirium in patients with COVID-19: A meta-analysis protocol for systematic review. BMJ Open. 2021; 11. doi:10.1136/bmjopen-2020-048323.
dcterms.references	Misra S, Kolappa K, Prasad M, Radhakrishnan D, Thakur KT, Solomon T et al. Frequency of neurologic manifestations in COVID-19. Neurology. 2021; 97: E2269–E2281.
dcterms.references	Søraas A, Bø R, Kalleberg KT, Støer NC, Ellingjord-Dale M, Landrø NI. Self-reported Memory Problems 8 Months after COVID-19 Infection. JAMA Netw Open. 2021; 4. doi:10.1001/jamanetworkopen.2021.18717.
dcterms.references	Poletti S, Palladini M, Mazza MG, De Lorenzo R, Irene B, Sara B et al. Long-term consequences of COVID-19 on cognitive functioning up to 6 months after discharge: role of depression and impact on quality of life. Eur Arch Psychiatry Clin Neurosci. 2021. doi:10.1007/s00406-02101346-9.
dcterms.references	Hopkins RO, Gale SD, Weaver LK. Brain atrophy and cognitive impairment in survivors of acute respiratory distress syndrome. Brain Inj. 2006; 20: 263–271.
dcterms.references	Mikkelsen ME, Christie JD, Lanken PN, Biester RC, Thompson BT, Bellamy SL et al. The Adult Respiratory Distress Syndrome Cognitive Outcomes Study. Am J Respir Crit Care Med. 2012; 185: 1307–1315
dcterms.references	Arica-Polat BS, Gundogdu AA, Cinar N, Uncu G, Ayas ZO, Iseri P et al. Evaluation of cognitive deficits in patients infected with COVID-19. Eur Rev Med Pharmacol Sci 2022; 26: 678–685.
dcterms.references	Sanford AM. Mild Cognitive Impairment. Clin Geriatr Med 2017; 33: 325–337.
dcterms.references	McCleery J, Laverty J, Quinn TJ. Diagnostic test accuracy of telehealth assessment for dementia and mild cognitive impairment. Cochrane Database Syst Rev 2021; 2021. doi:10.1002/14651858.CD013786.pub2.
dcterms.references	Davis DHJ, Creavin ST, Yip JLY, Noel-Storr AH, Brayne C, Cullum S. Montreal Cognitive Assessment for the detection of dementia. Cochrane Database Syst Rev 2021; 2021. doi:10.1002/14651858.CD010775.pub3.
dcterms.references	Liu YH, Chen Y, Wang QH, Wang LR, Jiang L, Yang Y et al. One-Year Trajectory of Cognitive Changes in Older Survivors of COVID-19 in Wuhan, China: A Longitudinal Cohort Study. JAMA Neurol. 2022. doi:10.1001/jamaneurol.2022.0461.
dcterms.references	Arksey H, O’Malley L. Scoping studies: towards a methodological framework. https://doi.org/101080/1364557032000119616 2007; 8: 19–32.
dcterms.references	Levac D, Colquhoun H, O’Brien KK. Scoping studies: Advancing the methodology. Implement Sci 2010; 5. doi:10.1186/1748-5908-5-69.
dcterms.references	Thomas A, Lubarsky S, Durning SJ, Young ME. Knowledge syntheses in medical education: Demystifying scoping reviews. Acad Med 2017; 92: 161–166.
dcterms.references	Davis K, Drey N, Gould D. What are scoping studies? A review of the nursing literature. Int J Nurs Stud 2009; 46: 1386–1400.
dcterms.references	Aromataris E, Munn Z. JBI Manual for Evidence Synthesis. JBI, 2020 doi:10.46658/jbimes-2001.
dcterms.references	Bussiek PBV, De Poli C, Bevan G. A scoping review protocol to map the evidence on interventions to prevent overweight and obesity in children. BMJ Open 2018; 8: 1–6.
dcterms.references	Anatomy of a Citation - PubMed - Searching Medical Literature - GSU Library Research Guides at Georgia State University. https://research.library.gsu.edu/c.php?g=115556&p=752194 (accessed 9 Aug2022).
dcterms.references	Mourad Ouzzani, Hossam Hammady, Zbys Fedorowicz and AE. Rayyan. M Rayyan — a web Mob app Syst Rev. 2016. doi:DOI: 10.1186/s13643-016-0384-4.
dcterms.references	Moher D, Liberati A, Tetzlaff J, Altman DG, Altman D, Antes G et al. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 2009; 6. doi:10.1371/JOURNAL.PMED.1000097.
dcterms.references	Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. PLoS Med 2021; 18. doi:10.1371/JOURNAL.PMED.1003583.
dcterms.references	González-Sanguino C, Ausín B, Castellanos MÁ, Saiz J, López-Gómez A, Ugidos C et al. Mental health consequences during the initial stage of the 2020 Coronavirus pandemic (COVID-19) in Spain. Brain Behav Immun 2020; 87: 172–176.
dcterms.references	Durbas A, Karaman H, Solman CH, Kaygisiz N, Ersoy Ö. Anxiety and Stress Levels Associated With COVID-19 Pandemic of University Students in Turkey: A Year After the Pandemic. Front psychiatry 2021; 12. doi:10.3389/FPSYT.2021.731348.
dcterms.references	Zaninotto P, Iob E, Demakakos P, Steptoe A. Immediate and Longer-Term Changes in the Mental Health and Well-being of Older Adults in England During the COVID-19 Pandemic. JAMA psychiatry 2022; 79: 151–159.
dcterms.references	Koliouli F, Canellopoulos L. Dispositional optimism, stress, post-traumatic stress disorder and post-traumatic growth in Greek general population facing the COVID-19 crisis. Eur J Trauma Dissociation 2021; 5: 100209.
dcterms.references	Duñabeitia JA, Mera F, Baro Ó, Jadad-garcia T. The impact of a home-based personalized computerized training program on cognitive dysfunction associated with Long COVID : a before-and-after feasibility study. 2022; : 1–16.
dcterms.references	Brough DN, Abel S, Priddle L. A service evaluation of a community project combining psychoeducation and mind-body complementary approaches to support those with long covid in the UK. Eur J Integr Med 2022; 55. doi:10.1016/J.EUJIM.2022.102182.
dcterms.references	Crivelli L, Calandri I, Corvalán N, Carello MA, Keller G, Martínez C et al. cognitive consequences of cOViD-19: results of a cohort study from South America. Arq Neuropsiquiatr 2022; 80: 240–247.
dcterms.references	García-Grimshaw M, Chirino-Pérez A, Flores-Silva FD, Valdés-Ferrer SI, Vargas-Martínez M de los Á, Jiménez-Ávila AI et al. Critical role of acute hypoxemia on the cognitive impairment after severe COVID-19 pneumonia: a multivariate causality model analysis. Neurol Sci 2022; 43: 2217–2229.
dcterms.references	Di Stadio A, Brenner MJ, De Luca P, Albanese M, D’ascanio L, Ralli M et al. Olfactory Dysfunction, Headache, and Mental Clouding in Adults with Long-COVID-19: What Is the Link between Cognition and Olfaction? A Cross-Sectional Study. Brain Sci 2022; 12. doi:10.3390/brainsci12020154.
dcterms.references	Amalakanti S, Arepalli KVR, Jillella JP. Cognitive assessment in asymptomatic COVID19 subjects. VirusDisease 2021; 32: 146–149.
dcterms.references	Checa A, Navas E, Valencia V, Alcivar J. Cognitive impairment in people with COVID-19 with mild-moderate symptoms in Ecuador. Rev Mex Neurocienc 2022; 23: 126–129.
dcterms.references	Abdelghani M, Atwa SA, Said A, Zayed NE, Abdelmoaty AA, Hassan MS. Cognitive after-effects and associated correlates among post-illness COVID-19 survivors: a cross-sectional study, Egypt. Egypt J Neurol psychiatry Neurosurg 2022; 58. doi:10.1186/S41983-022-00505-6.
dcterms.references	Moretta P, Ambrosino P, Lanzillo A, Marcuccio L, Fuschillo S, Papa A et al. Cognitive Impairment in Convalescent COVID-19 Patients Undergoing Multidisciplinary Rehabilitation: The Association with the Clinical and Functional Status. Healthc (Basel, Switzerland) 2022; 10. doi:10.3390/HEALTHCARE10030480.
dcterms.references	Almeria M, Cejudo JC, Sotoca J, Deus J, Krupinski J. Cognitive profile following COVID-19 infection: Clinical predictors leading to neuropsychological impairment. Brain, Behav Immun - Heal 2020; 9: 100163.
dcterms.references	Mikkelsen ME, Abramoff B, Elmore JG, Kunins L. COVID-19: evaluation and management of adults following acute viral illness. UpToDate Waltham, MA UpToDate Inc(Accessed Oct 30, 2021[Google Sch 2021.
dcterms.references	Rass V, Beer R, Schiefecker AJ, Lindner A, Kofler M, Ianosi BA et al. Neurological outcomes 1 year after COVID-19 diagnosis: A prospective longitudinal cohort study. Eur J Neurol 2022; 29: 1685–1696.
dcterms.references	Matos A de MB, Dahy FE, de Moura JVL, Marcusso RMN, Gomes ABF, Carvalho FMM et al. Subacute Cognitive Impairment in Individuals With Mild and Moderate COVID-19: A Case Series. Front Neurol 2021; 12: 1–8.
dcterms.references	Hadad R, Khoury J, Stanger C, Fisher T, Schneer S, Ben-Hayun R et al. Cognitive dysfunction following COVID-19 infection. J Neurovirol 2022; 28: 430.
dcterms.references	Gupta MDN, Anderson DOJ, Schmligen J, ... Clinical Guidelines: Long COVID-19. OhsuEdu; : 117.
dcterms.references	Altuna M, Sánchez-Saudinós MB, Lleó A. Cognitive symptoms after COVID-19. Neurol Perspect 2021; 1: S16–S24.
dcterms.references	Mikkelsen AME, Abramoff B. COVID-19 : Evaluation and management of adults with persistent symptoms following acute illness (" Long COVID "). UpToDate 2022; : 1–83.
dcterms.references	Liu K, Zhang W, Yang Y, Zhang J, Li Y, Chen Y. Respiratory rehabilitation in elderly patients with COVID-19: A randomized controlled study. Complement Ther Clin Pract 2020; 39. doi:10.1016/j.ctcp.2020.101166.
dcterms.references	Schwab K, Schwitzer E, Qadir N. Postacute Sequelae of COVID-19 Critical Illness. COVID-19 2022; 38: 455–472.
dcterms.references	García-Grimshaw M, Chirino-Pérez A, Flores-Silva FD, Valdés-Ferrer SI, Vargas-Martínez MÁ, Jiménez-Ávila AI et al. Critical role of acute hypoxemia on the cognitive impairment after severe COVID-19 pneumonia: a multivariate causality model analysis. Neurol Sci 2022; 43: 2217–2229.
thesis.degree.discipline	Facultad de Medicina	es_CO
thesis.degree.level	Especialización en Medicina Física y Rehabilitación	es_CO
thesis.degree.name	Especialista en Medicina Física y Rehabilitación	es_CO